Chiron Capital Management, LLC Pfizer Inc Transaction History

Chiron Capital Management, LLC

$113 Million
Q2 2025

A detailed history of Chiron Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Chiron Capital Management, LLC holds 73,072 shares of PFE stock, worth $1.8 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

73,072

Previous 75,035 2.62%

Holding current value

$1.8 Million

Previous $1.9 Million 6.84%

% of portfolio

1.57%

Previous 1.76%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$21.59 - $24.84 $42,381 - $48,760	-1,963 Reduced 2.62%	73,072 $1.77 Million
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $368,647 - $399,896	14,740 Added 24.45%	75,035 $1.9 Million
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $197,780 - $240,765	-7,975 Reduced 11.68%	60,295 $1.6 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $47,533 - $53,865	-1,716 Reduced 2.45%	68,270 $1.98 Million
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $13,286 - $15,569	526 Added 0.76%	69,986 $1.96 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $726,965 - $834,788	28,079 Added 67.85%	69,460 $1.93 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $299,136 - $388,545	-11,448 Reduced 21.67%	41,381 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.04 Million - $1.22 Million	32,426 Added 158.93%	52,829 $1.75 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $361,200 - $417,900	10,000 Added 96.13%	20,403 $748,000
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $88,548 - $115,277	2,248 Added 27.57%	10,403 $424,000
Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $45,925 - $59,950	-1,100 Reduced 11.89%	8,155 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $54,481 - $66,507	1,245 Added 15.54%	9,255 $405,000
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $1.12 Million - $1.33 Million	-24,022 Reduced 74.99%	8,010 $420,000
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $1.22 Million - $1.51 Million	-26,643 Reduced 45.41%	32,032 $1.66 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $243,622 - $361,130	-5,896 Reduced 9.13%	58,675 $3.47 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $2.75 Million - $3.53 Million	-69,938 Reduced 52.0%	64,571 $2.78 Million
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $693,781 - $785,937	-19,320 Reduced 12.56%	134,509 $5.27 Million
Q1 2021 May 18, 2021	BUY	$33.49 - $37.77 $3.04 Million - $3.43 Million	90,843 Added 144.23%	153,829 $5.57 Million
Q4 2020 Mar 05, 2021	SELL	$33.47 - $42.56 $473,265 - $601,798	-14,140 Reduced 18.33%	62,986 $2.32 Million
Q3 2020 Nov 19, 2020	BUY	$31.75 - $37.25 $2.45 Million - $2.87 Million	77,126 New	77,126 $2.83 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.

Account

Chiron Capital Management, LLC Pfizer Inc Transaction History